Radiotherapy in combined modality treatment;La radiotherapie dans un abord pluridisciplinaire

Revue des Maladies Respiratoires

Volumn 15, Issue 3 BIS, 1998, Pages 407-419

  Le Pechoux C ^a   Arriagada, R ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Altered fractionation; Chemotherapy; Combined modality treatment; Non small cell lung cancer; Radiotherapy

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; HUMAN; LUNG NON SMALL CELL CANCER; MULTIMODALITY CANCER THERAPY; RADIATION DOSE FRACTIONATION; ADJUVANT CHEMOTHERAPY; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; LUNG TUMOR; MORTALITY; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE CARE; PREOPERATIVE CARE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; REVIEW; TIME;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; CLINICAL TRIALS, PHASE II; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; HUMANS; LUNG NEOPLASMS; POSTOPERATIVE CARE; PREOPERATIVE CARE; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS; TIME FACTORS;

EID: 0031864584     PISSN: 07618425     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (105)

1. CHOI NCH, DOUCETTE JA : Improved survival of patients with unresectable non-small cell bronchogenic carcinoma by an innovated high-dose en-bloc radiotherapeutic approach. Cancer 1981;48:101-109.
2. Cox JD, HOLOYE PY, KOMAKI R : The role of radiotherapy in squamous, large cell and adenocarcinoma of the lung. Semin Oncol 1983;10:81-84.
3. PEREZ CA, PAJAK TF, RUBIN P et al. : Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiation therapy. Report by the Radiation Therapy Oncology Group. Cancer 1987;59:1874-1881.
4. SCHAAKE KONING C, SCHUSTER VITTERHOEVE L, HART G, GONZALEZ D : Pronostic factors of inoperable localized lung cancer treated by high-dose radiotherapy. Int J Radiat Oncol Biol Phys 1983;9:1023-1028.
5. BYHARDT RW : The evolution of Radiation Therapy Oncology Group (RTOG) protocols for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1995;32:1513-1515.
6. LE CHEVALIER T, ARRIAOADA R, QUOIX E et al. : Radiotherapy alone versus combined chemotherapy and radiotherapy in non-resectable non-small cell lung cancer : first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 1991;83:417-423.
7. DEWIT L : Combined treatment of radiation and cisdiamminedichloroplatinum (II) : a review of experimental and experimental data. Int J Radiat Oncol Biol Phys 1987;13:403-429.
8. SCHAAKE-KONING C, VAN DEN BOGART W, DALESIO O et al. : Radiosensitization by cytotoxic drugs : the EORTC experience by the Radiotherapy and Lung Cancer Cooperative Groups. Lung Cancer 1994; 10(suppl. 1): S263-S270.
9. VAN BELLE S : Do radiosensitizers enhance the treatment of patients with NSCLC ? The need for better models and alternative methods of treatment. Chest 1996:S115-S118.
10. BEGG AC, STEWART FA, DEWIT L, BARTELINK H : Interactions between cisplatin and radiation in experimental rodent tumors and normal tissues. In : Hill B, Bellamy A, (eds). Anti-tumor drug-radiation interactions. Boca Raton : CRC Press, 1989:154-170.
11. Cox JD : Presidential address : a paradigm for clinical research in radiation oncology. Int J Radiat Oncol Biol Phys 1987;13:1271-1281.
12. THAMES HD, WITHERS HR, PETERS LJ, FLETCHER GH: Changes in early and late radiation responses with altered dose fractionation : implications for dose-survival relationship. Int J Radiat Oncol Biol Phys 1982;8:219-226.
13. WITHERS HR, TAYLOR JM, MACIEJEWSKI B : The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-146.
14. Cox JD, AZARNIA N, BYHARDT RW et al. : A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy : possible survival benefit with > 69,6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small cell lung carcinoma. Report of Radiation Therapy Oncology Group 83-11. J Clin Oncol 1990;8:1543-1555.
15. SAUNDERS MI, DISCHE S : Continuous, hyperfractionated, accelerated radiotherapy (CHART) in non-small cell carcinoma of the bronchus. Int J Radiat Oncol Biol Phys 1990;19:1211-1215.
16. SAUNDERS MI, DISCHE S, BARRETT A, PARMAR MKB, HARVEY A, GIBSON D ON BEHALF OF THE CHART STEERING COMMITTEE : Randomised multicentre trials of CHART versus conventional radiotherapy in head and neck and non-small cell lung cancer : an interim report. Br J Cancer 1996;73:1455-1462.
17. SAUSE, WT, SCOTT C, TAYLOR S et al. : RTOG 8808 and ECOG 4588, preliminary results of a phase III trial in regionally advanced unresectable non-small cell lung carcinoma. J Natl Cancer Inst 1995;87:198-205.
18. MORNEX F, DANHIER S, VAN HOUTTE P : Cancers bronchiques non à petites cellules : toxicité de l'association radiothérapiechimiothérapie. Revue de la littérature. Bull Cancer 1994;81:5-13.
19. ARMSTRONG JG, BURMAN C, LEIBEL S et al. : Three dimensional conformal therapy may improve the therapeutic ratio of high-dose radiation therapy for lung cancer, Int J Radiat Oncol Biol Phys 1993;26:685-689.
20. GRAHAM MV, MATTHEWS JW, HARMS WB, EMAMI B, GLAZER HS, PURDY JA : Three-dimensional radiation treatment planning study for patients with carcinoma of the lung. Int J Radiat Oncol Biol Phys 1994;29:1105-1117.
21. EMAMI B, PEREZ CA : Carcinoma of the lung. In : Perez CA & Brady LW, (eds) : Principles and practice of radiation oncology. Philadelphia : JB Lippincott 1987:650-683.
22. ROSELL R, GOMEZ-CODINA J, CAMPS C et al. : A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. N Engl J Med 1994;330:153-158.
23. A non-small cell lung cancer. J Natl Cancer Inst 1994;86:673-680.
24. PAYNE DG : Is pre-operative or postoperative radiation therapy indicated in non-small cell cancer of the lung. Lung Cancer 1994;10(suppl. 4):S205-S212.
25. HILARIS BS, MARTINI N, LUOMANEN RKJ et al. : The value of properative radiation therapy in apical cancer of the lung. Surg Clin North Am 1974; 4:831-840.
26. PAULSON DL : The role of preoperative radiation therapy in the surgical management of carcinoma in the superior pulmonary sulcus. Front Radiat Ther Oncol 1970;5:177-187.
27. ANDERSON TM, MAY PM, HOLMES EC : Factors affecting survival in superior sulcus tumors. J Clin Oncol 1986;4:1598-1603.
28. GINSBERG RJ, PAYNE DG, SHAMJI F : Superior sulcus tumors In : Aisner J, Arriagada R, Green MR, Martini N & Perry MC, (eds) : Comprensive textbook of thoracic oncology 1996:375-387.
29. A non-small cell lung cancer. In : Aisner J, Arriagada R, Green MR, Martini N & Perry MC, (eds). Comprensive textbook of thoracic oncology 1996:351-374.
30. B). In : Aisner J, Arriagada R, Green MR, Martini N & Perry MC, (eds). Comprensive textbook of thoracic oncology 1996:388-415.
31. KIRSH MM, SLOAN H : Mediastinal metastases in bronchogenic carcinoma : influence of postoperative irradiation, cell type and location. Ann Thor Surg 1982;33:459-463.
32. MOUNTAIN CF, MCMURTRY MJ, FRAZIER OH et al. : Present status of postoperative adjuvant therapy for lung cancer. Cancer Bull 1980;32:108-112.
33. GREEN N, KUROHARA SS, GEORGE FW, GREWS QE : Post resection irradiation for primary lung cancer. Radiology 1975;116:405-407.
34. ARRIAGADA R, BRETEL JJ, LE CHEVALIER T : Adjuvant radiotherapy and surgery in lung cancer. In : Motta G (ed.). Lung Cancer. Frontiers in science and treatment. Genoa : Grafica LP. 1994:611-620.
35. NON-SMALL CELL LUNG CANCER COLLABORATIVE GROUP : Chemotherapy in non-small cell lung cancer : a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br Med Journal 1995;311:899-909.
36. IHDE DC : Chemotherapy of lung cancer. N Engl J Med 1992; 327:1434-1441.
37. DILLMAN RO, SEAGREN SL, PROPERT KJ et al. : A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 1990;323:940-945.
38. DILLMAN RP, SEAGREN SL, HERNDON J et al. : Randomized trial of induction chemotherapy plus radiation versus RT alone in stage III non-small cell lung cancer (NSCLC) : five years follow-up of CALGB 84-33 (Abstract). Proc Am Soc Clin Oncol 1993;12:329.
39. DILLMAN RP, HERNDON J, SEAGREN SL, EATON WL, GREEN MR : Improved survival in Stage III non-small cell lung cancer : Seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 Trial. J Natl Cancer Inst 1996;88:1210-1215.
40. GREGOR A, MAC BETH F, PAUL J et al. : Radical radiotherapy and chemotherapy in localized inoperable non-small cell lung cancer: a randomized trial. J Natl Cancer Inst 1993;85:997-998.
41. LE CHEVALIER T, ARRIAGADA R, TARAYRE M et al. : Significant effect of adjuvant chemotherapy on survival in locally advanced non-small cell lung carcinoma. J Natl Cancer Inst 1992;84:58.
42. MATTSON K, HOLSTI L, HOLSTI P et al. : Inoperable non-small cell lung cancer : radiation with or without chemotherapy. Eur J Cancer Clin Oncol 1988;24:477-482.
43. MINET P, BARTSCH P, CHEVALIER P et al. : Quality of life of inoperable non-small lung carcinoma. A randomized phase II study comparing radiotherapy alone and combined radiotherapy. Radiother Oncol 1987;8:217-230.
44. VAN HOUTTE P, KLASTERSKY J, RENAUD A et al. : Induction chemotherapy with cisplatin, etoposide, and vindesine before radiation therapy for NSCLC. In : Arriagada R, Le Chevalier T, (eds). Treatment modalities in lung cancer. Antibiotics and chemotherapy. Basel : Karger, 1988;47:131-137.
45. KUBOTA K, FURUSE K, KAWAHARA M et al. : Role of radiotherapy in combined modality treatment of locally advanced non-small cell lung cancer. J Clin Oncol 1994;12:1547-1552.
46. ARRIAGADA R, COSSET JM, LE CHEVALIER T, TUBIANA M : The value of adjunctive radiotherapy when chemotherapy is the major curative method, Int J Radiat Oncol Biol Phys 1990;19:1279-1284.
47. ARRIAGADA R, LE CHEVALIER T, BALDEYROU P et al. : Alternating radiotherapy and chemotherapy schedules in small cell lung cancer, limited disease, Int J Radiat Oncol Biol Phys 1985;11:1461-1467.
48. TUBIANA M, ARRIAGADA R, COSSET JM : Sequencing of drugs and radiation. The integrated alternating regimen. Cancer 1985;55:2131-2139.
49. COMELLA P, SCOPPA G, DAPONTE A et al. : Alternated approach with local irradiation and combination chemotherapy including cisplatin or carboplatin plus epirubicin and etoposide in intermediate stage non-small cell lung cancer. Cancer 1994;74:1874-1881.
50. B non-small cell lung cancer : results of a phase I/II study. Int J Radiat Oncol Biol Phys 1991;20:1047-1052.
51. B non-small cell lung cancer : report of a Cancer and Leukemia Group B phase II study 8636. Int J Radiat Oncol Biol Phys 1994;29:1085-1088.
52. COUGHLIN CT, RICHMOND RC : Biologic and clinical developments cisplatin combined with radiation : concepts, utility, projections for new trials, and the emergence of carboplatin. Semin Oncol 1989;16:31-43.
53. STEEL G : The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother Oncol 1988;7:31-53.
54. BLANKK C, ANSARI R, MONTRAVADI R et al. : Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small cell lung cancer : A Hoosier Oncology Group Protocol. J Clin Oncol 1995;13:1425-1429.
55. SIO O et al. : Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992;326:524-530.
56. SORESI E, CLERICI M, GRILLI R et al. : A randomized clinical trial comparing radiation therapy v radiation therapy plus cisdichlorodiammine platinum (II) in the treatment of locally advanced non-small cell lung cancer. Semin Oncol 1988;15:20-25.
57. TROVO MG, MINATEL E, FRANCHIN G et al. : Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1992;24:11-15.
58. HAZUKA MB, CROWLEY JJ, BUNN PA, O'ROURKE M, BRAUN TJ, LIVINGSTON RB : Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small cell lung cancer : Results of a phase II Southwest Oncology Group Study. J Clin Oncol 1994;12:1814-1820.
59. REBOUL F, VINCENT P, CHAUVET B et al. : Radiation therapy with concomitant continuous infusion cisplatin for unresectable non-small cell lung carcinoma. Cancer 1994;28:1251-1256.
60. REBOUL F, BREWER Y, VINCENT P, TAULELLE M : Cancers bronchiques non à petites cellules stade III : perspectives de la radiochimiothérapie concomitante. Bull Cancer: Radiothér 1995;82:28-34.
61. FURUSE K, KAWAHARA M, KODAMA N et al. : Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small cell lung cancer. J Clin Oncol 1995;13:869-875.
62. COY H, SAFRAN H : Preliminary analysis of a phase II study of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer. Semin Oncol 1995;22 (4 suppl.):S55-57.
63. A/B non-small cell carcinoma of the lung. Semin Oncol 1995;22 (4 suppl.):34-37.
64. GRECO FA, STROUP SL, GRAY JR, HAINSWORTH JD : Paclitaxel in combination chemotherapy with radiotherapy in patients with unresectable stage III non-small cell lung cancer. J Clin Oncol 1996;14:1642-1648.
65. RECKZEH B, MERTE H, PFLÜGER KH, PFAB R, WOLF, HAVEMAN F : Severe lymphocytopenia and interstitial pneumonia in patients treated with paclitaxel and simultaneous radiotherapy for non-small cell lung cancer. J Clin Oncol 1996;14:1071-1076.
66. SHAW EG, Mc GINNIS WL, JETT JR et al. : Pilot study of accelerated hyperfractionated thoracic radiation therapy plus concomitant etoposide and cisplatine chemotherapy in patients with unresectable stage III non-small cell lung carcinoma of the lung. J Natl Cancer Inst 1993;85:321-323.
67. BYHARDT RW, SCOTT CB, ETTINGER DS et al. : Concurrent hyperfractionated irradation and chemotherapy for unresectable non-small cell lung cancer. Results of Radiation Therapy Oncology Group 90-15. Cancer 1995;75:2337-2344.
68. LEE JS, SCOTT C, KOMAKI R et al. : Concurrent chemoradiation with oral etoposide and cisplatin for locally advanced inoperable non-small cell lung cancer : Radiation Therapy Oncology Group Protocol 91-06. J Clin Oncol 1996;14:1055-1064.
69. LE PECHOUX C, ARRIAGADA R, LE CHEVALIER T et al. : Concurrent cisplatin-Vindesine and hyperfractionated thoracic radiotherapy in locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1996;35:519-525.
70. B non-small cell lung cancer : results of a phase I-II study by the GOTHA group. Groupe d'Oncologie Thoracique des Régions Alpines. Eur J Cancer 1995;31A:342-348.
71. BALL D, BISHOP J, SMITH J et al. : A phase III study of accelerated radiotherapy with and without carboplatin in non-small cell lung cancer: an interim toxicity analysis of the first 100 patients. Int J Radiat Oncol Biol Phys 1995;31:261-272.
72. JEREMIC B, SHIBAMOTO Y, ACIMOVIC L, MILISAVLJEVIC S : Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small cell lung cancer : a randomized study. J Clin Oncol 1996;14:1065-1070.
73. JEREMIC B, SHIBAMOTO Y, ACIMOVIC L et al. : Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small cell lung cancer. J Clin Oncol 1995;13:452-458.
74. BYHARDT RW : Turning up the heat of non-small cell lung cancer : is the toxicity of concurrent cisplatin-based chemotherapy and accelerated fractionation acceptable. Int J Radiat Oncol Biol Phys 1995;31:431-433.
75. Cox JD, PAJAK TF, ASBELL S et al. : Interruptions of high-dose radiation therapy decrease long term survival of favourable patients with unresectable nonsmall cell carcinoma of the lung: analysis of 1244 cases from 3 Radiation Therapy Oncology Group (RTOG) trials. Int J Radiat Biol Phys Biol 1993;27:493-498.
76. B non-small cell lung cancer : mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995;13:1880-1892.
77. A-B lung carcinoma : a phase II study on continuous infusion of cisplatin and concurrent radiotherapy (plus adjuvant surgery). Lung Cancer 1993;10:73-84.
78. 0 non-small cell lung cancer. Cancer Treat Rep 1987;71:895-900.
79. FABER LP, KITTLE CK, WARREN WH et al. : Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer. Ann Thorac Surg 1989;47:669-677.
80. B non-small cell lung cancer after concomitant induction chemo-radiotherapy. Preliminary results of a pilot study (abstract). Proc Am Soc Clin Oncol 1995;14:1057.
81. LOKICH J, CHAFFEY J, NEPTUNE W : Concomitant 5-Fluoro-uracil infusion and high-dose radiation for stage in non-small cell lung cancer. Cancer 1989;64:1021-1025.
82. 2) non-small cell lung cancer. J Thorac Cardiovasc Surg 1996:111:123-133.
83. RECINE D, ROWLAND K, REDDY S et al. : Combined modality therapy for locally advanced non-small cell lung carcinoma. Cancer 1990;66:2270-2278.
84. RICE TW, ADELSTEIN DJ, KOKA A et al. : Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer. Ann Thorac Surg 1995;60:586-592.
85. SHERMAN D, STRAUSS G, SCHWARTZ J et al. : Combined modality therapy for regionally advanced stage III non-small cell lung cancer (NSCLC) employing neoadjuvant chemotherapy (CT), radiotherapy (RT) and surgery (S). Proc Am Soc Clin Oncol 1987;6:167.
86. 0 non-small cell lung cancer: long term follow-up in 41 patients. J Surg Oncol 1989;40:266-274.
87. A non-small cell carcinoma of the lung : report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 1992;10:1237-1244.
88. TAYLOR SG IV, TRIBULA M, BONOMI PD et al. : Simultaneous cisplatin fluorouracil infusion and radiation followed by surgical resection in regionally localized stage III, non-small cell lung cancer. Ann Thor Surg 1987;43:87-91.
89. WEIDEN PL, PINATADOSI S : Preoperative chemotherapy (cis-platin and fluorouracil) and radiation in stage III non-small cell lung cancer : a phase II study of the LCSG. J Natl Cancer Inst 1991;83:266-272.
90. 2) non-small cell lung cancer. Cancer and Leukemia Group B Thoracic Surgery Group. J Thorac Cardiovasc Surg 1995; 109:473-485.
91. 2). Analysis of Cancer and Leukemia Group B protocol 8935. Cancer 1996;77:2393-2399.
92. A non-small cell lung cancer including the Memorial Sloan-Kettering experience with induction MVP in patients with bulky medastinal lymph node metastases. Lung cancer 1995;12:S47-S57.
93. FOWLER WC, LANGER CJ, CURRAN WJ JR, KELLER SM : Postoperative complications after combined neoadjuvant treatment of lung cancer. Ann Thorac Surg 1993;55:986-989.
94. ARRIAGADA R, CUETO LADRON DE GUEVARA J, MOURIESSE H et al. : Limited small cell lung cancer treated by combined radiotherapy and chemotherapy : evaluation of a grading system of lung fibrosis. Radiother Oncol 1989;14:1-8.
95. BYHARDT RW, MARTIN L, PAJAK TF, SHIN KH, EMAMI B, Cox JD. The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer. Analysis of a Radiation Therapy Oncology Group protocol. Int J Radiat Oncol Biol Phys 1993;27:537-544
96. OKEN MM, CREECH RH, TORMEY DP : Toxicity and response criteria for the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655.
97. World Health Organization. WHO Handbook for reporting the results of cancer treatment, Geneva. WHO offset Publication 1979:48: 319.
98. ROACH M, GANDARA DR, Yuo HS et al. : Radiation pneumonitis following combined modality therapy for lung cancer : analysis of pronostic factors. J Clin Oncol 1995;13:2606-2612.
99. GROEN HJ, VAN DER MARK TW, VAN DER LEEST AH, DE VRIES EG, MULDER NH : Pulmonary function changes in lung-cancer patients treated with radiation with or without carboplatin. Am J Resp Critic Care Med 1995;152-2044-2048.
100. CHOI NC, KANAREK DJ : Toxicity of thoracic radiotherapy on pulmonary function in lung cancer. Lung Cancer 1994;10 (suppl.):S219-S230.
101. UMSAWASDI T, VALDIVIES OM, BARKLEY HT JR et al. : Esophageal complications from combined chemoradiotherapy in the treatment of non-small cell lung cancer. Int J Radiat Biol Phys Biol 1985;11:511-519.
102. VAN DEN KOGEL AJ : Editorial. Continuous, hyperfractionated, accelerated radiotherapy (CHART). Radiother Oncol: 1989;16:75-77.
103. MOMIN F, KRAUT M, LATTIN P et al. : Thrombocytopenia in patients receiving chemoradiotherapy and G-CSF for locally advanced non-small cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 1992;11:294.
104. BUNN PA, CROWLEY J, HAZUKA MB et al. : The role of GM-CSF in limited stage SCLC : a randomized phase III study of the southwest oncology group (SWOG). Proc Am Soc Clin Oncol 1992;11:292.
105. GREEN MR, Cox JD, ARDIZZONI A et al. : Endpoints for multi-modal clinical trials in stage III non-small cell lung cancer (NSCLC) : a consensus report. Lung Cancer 1994;11: S11-S13.